Erythrocyte membrane–liposome coating sustains circulation stability and targeted tumor therapy of CAR-T cells
BackgroundCAR-T therapy is limited by off-target sequestration in liver, spleen, and lungs, which reduces tumor delivery and risks systemic toxicity. Genetic engineering approaches are complex and carry safety concerns, necessitating efficient non-gene…